Literature DB >> 25575161

Structural comparisons of ligand-gated ion channels in open, closed, and desensitized states identify a novel propofol-binding site on mammalian γ-aminobutyric acid type A receptors.

Nicholas P Franks1.   

Abstract

BACKGROUND: Most anesthetics, particularly intravenous agents such as propofol and etomidate, enhance the actions of the neurotransmitter γ-aminobutyric acid (GABA) at the GABA type A receptor. However, there is no agreement as where anesthetics bind to the receptor. A novel approach would be to identify regions on the receptor that are state-dependent, which would account for the ability of anesthetics to affect channel opening by binding differentially to the open and closed states.
METHODS: The open and closed structures of the GABA type A receptor homologues Gloeobacter ligand-gated ion channel and glutamate-gated chloride channel were compared, and regions in the channels that move on channel opening and closing were identified. Docking calculations were performed to investigate possible binding of propofol to the GABA type A β3 homomer in this region.
RESULTS: A comparison between the open and closed states of the Gloeobacter ligand-gated ion channel and glutamate-gated chloride channel channels identified a region at the top of transmembrane domains 2 and 3 that shows maximum movement when the channels transition between the open and closed states. Docking of propofol into the GABA type A β3 homomer identified two putative binding cavities in this same region, one with a high affinity and one with a lower affinity. Both cavities were adjacent to a histidine residue that has been photolabeled by a propofol analog, and both sites would be disrupted on channel closing.
CONCLUSIONS: These calculations support the conclusion of a recent photolabeling study that propofol acts at a site at the interface between the extracellular and transmembrane domains, close to the top of transmembrane domain 2.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25575161     DOI: 10.1097/ALN.0000000000000588

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  18 in total

1.  A Cysteine Substitution Probes β3H267 Interactions with Propofol and Other Potent Anesthetics in α1β3γ2L γ-Aminobutyric Acid Type A Receptors.

Authors:  Alex T Stern; Stuart A Forman
Journal:  Anesthesiology       Date:  2016-01       Impact factor: 7.892

2.  γ-Aminobutyric Acid Type A Receptor Modulation by Etomidate Analogs.

Authors:  Ervin Pejo; Peter Santer; Lei Wang; Philip Dershwitz; S Shaukat Husain; Douglas E Raines
Journal:  Anesthesiology       Date:  2016-03       Impact factor: 7.892

3.  Analysis of GABAA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites.

Authors:  Daniel J Shin; Allison L Germann; Douglas F Covey; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2018-10-18       Impact factor: 4.436

4.  Alkylphenol inverse agonists of HCN1 gating: H-bond propensity, ring saturation and adduct geometry differentially determine efficacy and potency.

Authors:  Rebecca L Joyce; Nicole P Beyer; Georgia Vasilopoulos; Kellie A Woll; Adam C Hall; Roderic G Eckenhoff; Dipti N Barman; J David Warren; Gareth R Tibbs; Peter A Goldstein
Journal:  Biochem Pharmacol       Date:  2019-02-13       Impact factor: 5.858

5.  Manipulations of extracellular Loop 2 in α1 GlyR ultra-sensitive ethanol receptors (USERs) enhance receptor sensitivity to isoflurane, ethanol, and lidocaine, but not propofol.

Authors:  A Naito; K H Muchhala; J Trang; L Asatryan; J R Trudell; G E Homanics; R L Alkana; D L Davies
Journal:  Neuroscience       Date:  2015-03-28       Impact factor: 3.590

6.  Barbiturates Bind in the GLIC Ion Channel Pore and Cause Inhibition by Stabilizing a Closed State.

Authors:  Zaineb Fourati; Reinis Reinholds Ruza; Duncan Laverty; Emmanuelle Drège; Sandrine Delarue-Cochin; Delphine Joseph; Patrice Koehl; Trevor Smart; Marc Delarue
Journal:  J Biol Chem       Date:  2016-12-16       Impact factor: 5.157

Review 7.  Towards a Comprehensive Understanding of Anesthetic Mechanisms of Action: A Decade of Discovery.

Authors:  Hugh C Hemmings; Paul M Riegelhaupt; Max B Kelz; Ken Solt; Roderic G Eckenhoff; Beverley A Orser; Peter A Goldstein
Journal:  Trends Pharmacol Sci       Date:  2019-05-27       Impact factor: 14.819

8.  Propofol Attenuates Inflammatory Response in LPS-Activated Microglia by Regulating the miR-155/SOCS1 Pathway.

Authors:  Xinxun Zheng; Hongbing Huang; Jianjun Liu; Minghua Li; Min Liu; Tao Luo
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

9.  Propofol Is an Allosteric Agonist with Multiple Binding Sites on Concatemeric Ternary GABAA Receptors.

Authors:  Daniel J Shin; Allison L Germann; Alexander D Johnson; Stuart A Forman; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2017-11-30       Impact factor: 4.436

10.  Mutational Analysis of the Putative High-Affinity Propofol Binding Site in Human β3 Homomeric GABAA Receptors.

Authors:  Megan M Eaton; Lily Q Cao; Ziwei Chen; Nicholas P Franks; Alex S Evers; Gustav Akk
Journal:  Mol Pharmacol       Date:  2015-07-23       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.